August 4, 2008 - There is no statistically significant difference between iopamidol-370 (Isovue-370) and iodixanol-320 ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
July 31, 2008 - Bristol-Myers Squibb Co. today offered $4.5 billion in cash for its cancer drug partner, ImClone Systems ...
July 29, 2008 – GE Healthcare reported results from a Phase I clinical trial of GE-067, a [18F]-labeled PET diagnostic ...
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
July 24, 2008 – Covidien recently launched the Optistar Elite contrast delivery system, designed to inject contrast ...
July 17, 2008 - GE Healthcare’s iodixanol, an isosmolar contrast medium, shows lower incidence of elevated serum ...
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
The FDA approved Bayer HealthCare Pharmaceuticals’s EOVIST (Gadoxetate Disodium) Injection, a gadolinium-based contrast ...
July 8, 2008 – The FDA approved Bayer HealthCare Pharmaceuticals’s EOVIST (Gadoxetate Disodium) Injection, a gadolinium ...
June 22, 2008 - Customized microscopic magnets that could possibly be injected into the body could add color to magnetic ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
June 18, 2008 – MEDRAD gained FDA 510(k) clearance for a new Fluorodeoxyglucose (FDG) infusion system for positron ...
June 18, 2008 – Bracco Diagnostics showcased its Cardiac PET Perfusion Imaging with CardioGen-82, a Rubidium Rb 82 ...
June 17, 2008 – Findings indicate that when used with PET technology, BMS747158 demonstrates a favorable radiation ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
June 13, 2008 - MEDRAD signed a distribution and co-marketing partnership agreement with PETNET Solutions, a fully owned ...
June 12, 2008 – The FDA designated for priority review, the New Drug Application (NDA) for GE’s AdreView, a molecular ...
June 12, 2008 - There is a lack of universally applied standards for administering radiopharmaceutical doses to children ...
June 13, 2008 - The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit ...
June 10, 2008 - The use of ultrasound contrast agents during stress echocardiograms is safe, according to results ...
Acusphere has submitted a New Drug Application (NDA) to the FDA for approval to market Imagify (Perflubutane Polymer ...
ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use ...
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
August 05, 2008 